New Form 8-K - TITAN PHARMACEUTICALS INC Filed: 2025-06-27 AccNo: 0001829126-25-004764 Size: 749 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
New Form 8-K - Fulcrum Therapeutics, Inc. Filed: 2025-06-27 AccNo: 0001193125-25-151276 Size: 148 KB Item 5.07: Submission of Matters to a Vote of Security Holders